Literature DB >> 32270704

An overview of drug discovery and development.

Nurken Berdigaliyev1, Mohamad Aljofan1.   

Abstract

A new medicine will take an average of 10-15 years and more than US$2 billion before it can reach the pharmacy shelf. Traditionally, drug discovery relied on natural products as the main source of new drug entities, but was later shifted toward high-throughput synthesis and combinatorial chemistry-based development. New technologies such as ultra-high-throughput drug screening and artificial intelligence are being heavily employed to reduce the cost and the time of early drug discovery, but they remain relatively unchanged. However, are there other potentially faster and cheaper means of drug discovery? Is drug repurposing a viable alternative? In this review, we discuss the different means of drug discovery including their advantages and disadvantages.

Entities:  

Keywords:  drug repurposing; high throughput; natural sources; small molecule

Mesh:

Year:  2020        PMID: 32270704     DOI: 10.4155/fmc-2019-0307

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  25 in total

Review 1.  Molecular photoswitches in aqueous environments.

Authors:  Jana Volarić; Wiktor Szymanski; Nadja A Simeth; Ben L Feringa
Journal:  Chem Soc Rev       Date:  2021-11-15       Impact factor: 54.564

Review 2.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

3.  Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation.

Authors:  Erica Gazzillo; Stefania Terracciano; Dafne Ruggiero; Marianna Potenza; Maria Giovanna Chini; Gianluigi Lauro; Katrin Fischer; Robert Klaus Hofstetter; Assunta Giordano; Oliver Werz; Ines Bruno; Giuseppe Bifulco
Journal:  Molecules       Date:  2022-06-16       Impact factor: 4.927

Review 4.  Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.

Authors:  Mootaz M Salman; Zaid Al-Obaidi; Philip Kitchen; Andrea Loreto; Roslyn M Bill; Richard Wade-Martins
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 5.  Drug targets for COVID-19 therapeutics: Ongoing global efforts.

Authors:  Ambrish Saxena
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

6.  Design, Synthesis, and Antibacterial and Antifungal Activities of Novel Trifluoromethyl and Trifluoromethoxy Substituted Chalcone Derivatives.

Authors:  Surendra Babu Lagu; Rajendra Prasad Yejella; Richie R Bhandare; Afzal B Shaik
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-09

Review 7.  Impact of structural biologists and the Protein Data Bank on small-molecule drug discovery and development.

Authors:  Stephen K Burley
Journal:  J Biol Chem       Date:  2021-03-17       Impact factor: 5.157

8.  Exploring existing drugs: proposing potential compounds in the treatment of COVID-19.

Authors:  Eva Rahman Kabir; Nashrah Mustafa; Nahid Nausheen; Mohammad Kawsar Sharif Siam; Easin Uddin Syed
Journal:  Heliyon       Date:  2021-02-25

Review 9.  Deep Learning in Virtual Screening: Recent Applications and Developments.

Authors:  Talia B Kimber; Yonghui Chen; Andrea Volkamer
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

10.  Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond.

Authors:  Dimitri Poddighe; Mohamad Aljofan
Journal:  Antivir Chem Chemother       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.